{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:07:40Z","timestamp":1789704460943,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"DOI":"10.7759\/cureus.20532","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T13:34:33Z","timestamp":1640007273000},"source":"Crossref","is-referenced-by-count":7,"title":["Acotiamide and Functional Dyspepsia: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Dhan B","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravash","family":"Budhathoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prarthana","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manita","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabesh","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yub Raj","family":"Sedhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhesh Raj","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasey Ali Yadullahi","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack J","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006, 130:1466-79. 10.1053\/j.gastro.2005.11.059","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"Aziz I","year":"2018","unstructured":"Aziz I, Palsson OS, T\u00f6rnblom H, Sperber AD, Whitehead WE, Simr\u00e9n M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018, 3:252-62. 10.1016\/S2468-1253(18)30003-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","article-title":"Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach","volume":"294","author":"Ogishima M","year":"2000","unstructured":"Ogishima M, Kaibara M, Ueki S, Kurimoto T, Taniyama K. Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach. J Pharmacol Exp Ther. 2000, 294:33-7.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339:b2700. 10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01261.x","article-title":"A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia","volume":"21","author":"Tack J","year":"2009","unstructured":"Tack J, Masclee A, Heading R, et al.. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil. 2009, 21:272-80. 10.1111\/j.1365-2982.2009.01261.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301454","article-title":"A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia","volume":"61","author":"Matsueda K","year":"2012","unstructured":"Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012, 61:821-8. 10.1136\/gutjnl-2011-301454","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1260-7","article-title":"A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia","volume":"52","author":"Nakamura K","year":"2017","unstructured":"Nakamura K, Tomita T, Oshima T, et al.. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia. J Gastroenterol. 2017, 52:602-10. 10.1007\/s00535-016-1260-7","journal-title":"J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01897.x","article-title":"Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography","volume":"24","author":"Kusunoki H","year":"2012","unstructured":"Kusunoki H, Haruma K, Manabe N, et al.. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012, 24:540-e251. 10.1111\/j.1365-2982.2012.01897.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01449.x","article-title":"Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage","volume":"22","author":"Matsueda K","year":"2010","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010, 22:618-e173. 10.1111\/j.1365-2982.2009.01449.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/541950","article-title":"Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis","volume":"2014","author":"Xiao G","year":"2014","unstructured":"Xiao G, Xie X, Fan J, et al.. Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis. Sci World J. 2014, 2014:541950. 10.1155\/2014\/541950","journal-title":"Sci World J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009431.pub3","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon R","year":"2018","unstructured":"Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Leontiadis GI, Moayyedi P. Prokinetics for functional dyspepsia. Cochrane Database Syst Rev. 2018, 10:CD009431. 10.1002\/14651858.CD009431.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74139-acotiamide-and-functional-dyspepsia-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:48Z","timestamp":1707507288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74139-acotiamide-and-functional-dyspepsia-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.20532","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}